Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Redcare Pharmacy (DE:RDC)
XETRA:RDC
Holding DE:RDC?
Track your performance easily
RDC Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€95.60 - €153.80
Previous Close€152
Volume43.75K
Average Volume (3M)57.46K
Market Cap
€3.09B
Enterprise Value€3.16B
Total Cash (Recent Filing)€184.00M
Total Debt (Recent Filing)€255.19M
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Nov 05, 2024EPS Estimate
-€0.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares OutstandingN/A
10 Day Avg. Volume62,117
30 Day Avg. Volume57,456
Standard Deviation0.17
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.35
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€160.40Price Target Upside5.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Redcare Pharmacy News
Bulls Say, Bears Say
Bulls Say
Innovation And StrategyRedcare Pharmacy is focusing on innovations such as Telemedicine and the introduction of the electronic prescription in Germany.
Market GrowthRedcare Pharmacy looks set to benefit significantly from the introduction of e-prescriptions in Germany and is clearly gaining market share against its key competitor DocMorris.
Sales PerformanceSales were up 21% to €574m with OTC sales up 20% and German Rx up 81% year-over-year.
Bears Say
Financial GuidanceThe adjusted EBITDA margin guidance of 1.2% to 2.2% indicates significant additional marketing expenses of approximately €30m, which may concern investors.
Financial PerformanceA margin of 2.7% represents a slight decline year-over-year, attributed to elevated marketing expenses, which could be a point of concern for financial performance.
Legal IssuesThe uncertainty surrounding the final ruling on DocMorris's request for €18.5m in damages plus interest could negatively impact investor perceptions of the involved companies.
---
Options Prices
Currently, No data available
---
Ownership Overview
2.37% Insiders
9.50% Mutual Funds
<0.01% Other Institutional Investors
83.62% Public Companies and
Individual Investors
RDC FAQ
What was Redcare Pharmacy’s price range in the past 12 months?
Redcare Pharmacy lowest stock price was €95.60 and its highest was €153.80 in the past 12 months.
What is Redcare Pharmacy’s market cap?
Currently, no data Available
When is Redcare Pharmacy’s upcoming earnings report date?
Redcare Pharmacy’s upcoming earnings report date is Nov 05, 2024 which is today.
How were Redcare Pharmacy’s earnings last quarter?
Redcare Pharmacy released its earnings results on Jul 30, 2024. The company reported -€0.349 earnings per share for the quarter, missing the consensus estimate of -€0.08 by -€0.269.
Is Redcare Pharmacy overvalued?
According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued.
Does Redcare Pharmacy pay dividends?
Redcare Pharmacy does not currently pay dividends.
What is Redcare Pharmacy’s EPS estimate?
Redcare Pharmacy’s EPS estimate is -€0.66.
How many shares outstanding does Redcare Pharmacy have?
Redcare Pharmacy has 20,342,485 shares outstanding.
What happened to Redcare Pharmacy’s price movement after its last earnings report?
Redcare Pharmacy reported an EPS of -€0.349 in its last earnings report, missing expectations of -€0.08. Following the earnings report the stock price went up 9.33%.
Which hedge fund is a major shareholder of Redcare Pharmacy?
Currently, no hedge funds are holding shares in DE:RDC
---
Redcare Pharmacy Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€160.40 (5.39% Upside)
€160.40 (5.39% Upside)
Insider Transactions
Sold Shares
Worth €539.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.04%
12-Months-Change
Fundamentals
Return on Equity
-1.94%
Trailing 12-Months
Asset Growth
-6.53%
Trailing 12-Months
Company Description
Redcare Pharmacy
Shop Apotheke Europe NV operates an online pharmacy store. Its product portfolio is focused on non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment. Geographically, it has a presence in Germany, Belgium, Spain, France, and Italy.
---
RDC Stock 12 Month Forecast
Average Price Target
€160.40
▲(5.39% Upside)
Technical Analysis
Best Analysts Covering RDC
1 Year
1 Year Success Rate
26/27 ratings generated profit
1 Year Average Return
+82.73%
reiterated a buy rating last month
Copying Christian Salis's trades and holding each position for 1 Year would result in 96.30% of your transactions generating a profit, with an average return of +82.73% per trade.
---